Exact Sciences stock has seen its fair value price target rise slightly, moving from $69.16 to $70.25, as analyst sentiment shifts to reflect the company’s anticipated growth. This adjustment comes as ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that results from the Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback